AC Immune to discontinue development of ACI-91 small molecule

31.January 2013 08:00 CET
English
Français
Deutsch
  • Phase II results do not demonstrate efficacy of ACI-91 in patients with advanced Alzheimer's disease
  • ACI-91 drug in-licensed with different mode-of-action from in-house therapies under development